Regencell Bioscience Holdings (RGC) Other Non-Current Assets (2020 - 2025)

Regencell Bioscience Holdings' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $93439.0 for Q4 2025.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $93439.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $93439.0 (changed N/A YoY) and the FY2025 annual result came in at $92950.0, down 4.85% from the prior year.
• Other Non-Current Assets was $93439.0 for Q4 2025 at Regencell Bioscience Holdings, up from $92950.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $114302.0 in Q2 2022 and bottomed at $19106.0 in Q2 2021.
• A 5-year average of $87663.3 and a median of $95561.5 in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 498.25% — and 2024, when it declined 9.97%.
• Regencell Bioscience Holdings' Other Non-Current Assets stood at $19106.0 in 2021, then soared by 498.25% to $114302.0 in 2022, then declined by 5.08% to $108499.0 in 2023, then retreated by 9.97% to $97684.0 in 2024, then dropped by 4.35% to $93439.0 in 2025.
• Business Quant data shows RGC's Other Non-Current Assets at $93439.0 in Q4 2025, $92950.0 in Q2 2025, and $97684.0 in Q2 2024.